Table 3 |
|||||
|
Median of Detection and recognition thresholds in cancer patients in the second chemotherapy cycle and controls |
|||||
|
Threshold |
Cases (μmol/ml) |
Controls (μmol/ml) |
p * |
Mean rank differences (z) |
p** |
|
|
|||||
|
Sweet DT |
6.4 ± 4 |
4.4 ± 1.7 |
0.05 |
2.22 |
0.027 |
|
Sweet RT |
8.9 ± 4 |
8.1 ± 5.8 |
0.58 |
0.98 |
0.325 |
|
Bitter DT |
92 ± 5.7 |
89.3 ± 16 |
0.30 |
0.85 |
0.398 |
|
Bitter RT |
100 ± 8 |
95 ± 7 |
0.04 |
0.63 |
0.527 |
|
Umami DT |
1.1 ± 0.8 |
0.84 ± 0.6 |
0.19 |
0.04 |
0.96 |
|
Umami RT |
2.1 ± 0.7 |
1.9 ± 0.7 |
0.3 |
0.10 |
0.919 |
|
|
|||||
|
μmol/ml = micromol/millimeter *Mann-Whitney U test ** Wilcoxon Signed Ranks test |
|||||
|
Sánchez-Lara et al. Nutrition Journal 2010 9:15 doi:10.1186/1475-2891-9-15 |
|||||